Therapeutics/Diagnostics

Top Story

Model identifies risk for inadequate bowel cleansing in hospitalized patients

March 20, 2020
Q&A With Healio Rheumatology

Doing the 'Patent Dance:' Untangling biosimilar litigation for physicians

March 20, 2020
Despite their much-touted potential to drastically lower the cost of pricey biologics and improve care for patients across a spectrum of diseases, biosimilars have been…
In the Journals

Serum biomarker panel may help predict Crohn’s diagnosis

March 18, 2020
A panel of serum antibodies and proteins helped identify patients who later received a diagnosis of Crohn’s disease within 5 years, according to research published…
Meeting News

Anti-IL-23 therapy effective in treating IBD

March 9, 2020
MAUI, Hawaii — Interleukin-23 inhibitors are effective for induction and maintenance of remission in Crohn’s disease and ulcerative colitis, according to an…
More Headlines »